Series E warrants (expires five years from the date of the initial exercise of the Series C Warrants):
- 819,914 warrants exercisable at $32.00 ($26,237,248)
Series G warrants (expires five years from the initial exercise date):
- 4,916,603 warrants exercisable at $4.37 ($21,485,555)
Series H warrants (expires five years from the initial exercise date):
- 10,909,100 warrants exercisable at $1.65 ($18,000,015)
Advisor warrants 3:
- 114,000 warrants exercisable at $5.31 ($605,340)
Advisor warrants 4:
- 114,000 warrants exercisable at $0.86 ($98,040)
Stock options:
- 2,296,981 options with a weighted average exercise price equal to $12.99 ($29,837,783)
Series D Convertible Preferred Stock:
- 7,277 shares convertible into an aggregate of 4,319,704 shares of common stock
To be raised from exercised warrants & options: $148,823,994